Shepherd's purse, Capsella bursa-pastoris (L.) Medik., has been considered a health food for centuries in Asia and is known to contain the isothiocyanate compound sulforaphane. In this study, we evaluated the anti-inflammatory and antibacterial properties of a sulforaphane-containing solution (SCS) isolated from shepherd's purse. SCS had significant anti-inflammatory activity indicated by the d...

Nosocomial infection caused by methicillin-resistant Staphylococcus aureus (MRSA) or vancomycin-resistant Enterococci (VRE) has become a great deal of recent concern. Although a number of cephalosporins had been synthesized in the past, few of them was effective against these resistant bacteria. Recently, TOC-39and TOC-50^3) bearing vinyl-thio linkage attached by substituted pyridines at C-3 we...

2-(2',4'-Dibromophenoxy)-4,6-dibromophenol isolated from the marine sponge Dysidea granulosa (Bergquist) collected off the coast of Lakshadweep islands, Indian Ocean, exhibited potent and broad spectrum in-vitro antibacterial activity, especially against methicillin resistant Staphylococcus aureus (MRSA), methicillin sensitive Staphylococcus aureus (MSSA), vancomycin resistant Enterococci (VRE)...

Enterococcus faecium strain 10/96A (VanD4) was the first vancomycin-resistant enterococcus (VRE) isolated in Brazil. Subsequent Brazilian VRE strains have all had the VanA phenotype. Multilocus sequence typing showed that strain 10/96A was isolated sporadically, has a unique sequence type (ST 281), and was not the progenitor of the VRE strains isolated from hospital outbreaks in Brazil.

Introduction Methicillin-Resistant Staphylococcus aureus (MRSA) and Vancomycin-Resistant Enterococcus (VRE) have accomplished important rates of colonization and infection in most intensive care units. These multidrug-resistant strains of MRSA and VRE have been causing serious problems in health care. The rising clinical importance of drug-resistant pathogens has lent necessity to drug developm...

BACKGROUND Vancomycin-resistant enterococci (VRE) cause severe infections among patients with malignancy, and these infections are usually preceded by gastrointestinal colonization. METHODS We searched the PubMed and EMBASE databases (up to May 26, 2016) to identify studies that reported data on VRE gastrointestinal colonization among patients with solid or hematologic malignancy. RESULTS T...

Avoparcin was used as a feed additive in New Zealand broiler production from 1977 until June 2000. We report here on the effects of the usage and discontinuation of avoparcin on the prevalence of vancomycin-resistant enterococci (VRE) in broilers. Eighty-two VRE isolates were recovered from poultry fecal samples between 2000 and mid-2001. VRE isolates were only obtained from broiler farms that ...

Vancomycin-resistant enterococcus (VRE) is now one of the leading causes of nosocomial infections in the United States. Hematopoietic stem cell transplantation (HSCT) recipients are at increased risk of VRE colonization and infection. VRE has emerged as a major cause of bacteremia in this population, raising important clinical questions regarding the role and impact of VRE colonization and infe...

(VRE) are very serious problems because of the resistance against not only vancomycin but also many types of antimicrobials. Although enterococci are less virulent, they cause nosocomial infections. VRE was noted from the U.K. and France at first, and then they have become one of the most important nosocomial pathogens worldwide. In the case of the United States, the percentage of VRE in entero...

Vancomycin resistant enterococci (VRE) causes health-care related infections such as endocarditis, meningitis, bacteremia, Septicemia and gastrointestinal tract infections in immunocompromised patients. VRE are emerging therapeutic dilemma due to high resistance against commonly used antibiotics including vancomycin. The present study was conducted to investigate the prevalence of VRE in clinic...